Skip to main content
NCBI home page
Gut logoLink to Gut
. 2000 Jan;46(Suppl 1):I1–I8. doi: 10.1136/gut.46.suppl_1.I1

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease

E Scott, I Gaywood, B Scott
PMCID: PMC1766735  PMID: 10647595

Full Text

The Full Text of this article is available as a PDF (101.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi J. D., Bensen W. G., Bianchi F., Cividino A., Pillersdorf S., Sebaldt R. J., Tugwell P., Gordon M., Steele M., Webber C. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol. 1996 Jun;23(6):995–1000. [PubMed] [Google Scholar]
  2. Adachi J. D., Bensen W. G., Brown J., Hanley D., Hodsman A., Josse R., Kendler D. L., Lentle B., Olszynski W., Ste-Marie L. G. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):382–387. doi: 10.1056/NEJM199708073370603. [DOI] [PubMed] [Google Scholar]
  3. Adachi J., Cranney A., Goldsmith C. H., Bensen W. G., Bianchi F., Cividino A., Craig G. L., Kaminska E., Sebaldt R. J., Papaioannou A. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol. 1994 Oct;21(10):1922–1926. [PubMed] [Google Scholar]
  4. Bijlsma J. W., Raymakers J. A., Mosch C., Hoekstra A., Derksen R. H., Baart de la Faille H., Duursma S. A. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol. 1988 Apr-Jun;6(2):113–119. [PubMed] [Google Scholar]
  5. Bjarnason I., Macpherson A., Mackintosh C., Buxton-Thomas M., Forgacs I., Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut. 1997 Feb;40(2):228–233. doi: 10.1136/gut.40.2.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Black D. M., Cummings S. R., Karpf D. B., Cauley J. A., Thompson D. E., Nevitt M. C., Bauer D. C., Genant H. K., Haskell W. L., Marcus R. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996 Dec 7;348(9041):1535–1541. doi: 10.1016/s0140-6736(96)07088-2. [DOI] [PubMed] [Google Scholar]
  7. Bodé S., Hassager C., Gudmand-Høyer E., Christiansen C. Body composition and calcium metabolism in adult treated coeliac disease. Gut. 1991 Nov;32(11):1342–1345. doi: 10.1136/gut.32.11.1342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Braun J. J., Birkenhäger-Frenkel D. H., Rietveld A. H., Juttmann J. R., Visser T. J., Birkenhäger J. C. Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study. Clin Endocrinol (Oxf) 1983 Aug;19(2):265–273. doi: 10.1111/j.1365-2265.1983.tb02989.x. [DOI] [PubMed] [Google Scholar]
  9. Buckley L. M., Leib E. S., Cartularo K. S., Vacek P. M., Cooper S. M. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996 Dec 15;125(12):961–968. doi: 10.7326/0003-4819-125-12-199612150-00004. [DOI] [PubMed] [Google Scholar]
  10. Caraceni M. P., Molteni N., Bardella M. T., Ortolani S., Nogara A., Bianchi P. A. Bone and mineral metabolism in adult celiac disease. Am J Gastroenterol. 1988 Mar;83(3):274–277. [PubMed] [Google Scholar]
  11. Cauley J. A., Seeley D. G., Ensrud K., Ettinger B., Black D., Cummings S. R. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1995 Jan 1;122(1):9–16. doi: 10.7326/0003-4819-122-1-199501010-00002. [DOI] [PubMed] [Google Scholar]
  12. Christiansen C., Christensen M. S., Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 1981 Feb 28;1(8218):459–461. doi: 10.1016/s0140-6736(81)91848-1. [DOI] [PubMed] [Google Scholar]
  13. Clements D., Compston J. E., Evans W. D., Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut. 1993 Nov;34(11):1543–1546. doi: 10.1136/gut.34.11.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clements D., Motley R. J., Evans W. D., Harries A. D., Rhodes J., Coles R. J., Compston J. E. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol. 1992 Dec;27(12):1055–1060. doi: 10.3109/00365529209028138. [DOI] [PubMed] [Google Scholar]
  15. Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B., Speizer F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15;332(24):1589–1593. doi: 10.1056/NEJM199506153322401. [DOI] [PubMed] [Google Scholar]
  16. Compston J. E., Cooper C., Kanis J. A. Bone densitometry in clinical practice. BMJ. 1995 Jun 10;310(6993):1507–1510. doi: 10.1136/bmj.310.6993.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Compston J. E., Judd D., Crawley E. O., Evans W. D., Evans C., Church H. A., Reid E. M., Rhodes J. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987 Apr;28(4):410–415. doi: 10.1136/gut.28.4.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Corazza G. R., Di Sario A., Cecchetti L., Tarozzi C., Corrao G., Bernardi M., Gasbarrini G. Bone mass and metabolism in patients with celiac disease. Gastroenterology. 1995 Jul;109(1):122–128. doi: 10.1016/0016-5085(95)90276-7. [DOI] [PubMed] [Google Scholar]
  19. Cummings S. R., Black D. M., Nevitt M. C., Browner W., Cauley J., Ensrud K., Genant H. K., Palermo L., Scott J., Vogt T. M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9;341(8837):72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
  20. Dawson-Hughes B., Harris S. S., Krall E. A., Dallal G. E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997 Sep 4;337(10):670–676. doi: 10.1056/NEJM199709043371003. [DOI] [PubMed] [Google Scholar]
  21. Di Munno O., Beghe F., Favini P., Di Giuseppe P., Pontrandolfo A., Occhipinti G., Pasero G. Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium. Clin Rheumatol. 1989 Jun;8(2):202–207. doi: 10.1007/BF02030075. [DOI] [PubMed] [Google Scholar]
  22. Dykman T. R., Haralson K. M., Gluck O. S., Murphy W. A., Teitelbaum S. L., Hahn T. J., Hahn B. H. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1984 Dec;27(12):1336–1343. doi: 10.1002/art.1780271203. [DOI] [PubMed] [Google Scholar]
  23. Eastell R. Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. J Intern Med. 1995 May;237(5):439–447. doi: 10.1111/j.1365-2796.1995.tb00868.x. [DOI] [PubMed] [Google Scholar]
  24. Eastell R., Reid D. M., Compston J., Cooper C., Fogelman I., Francis R. M., Hosking D. J., Purdie D. W., Ralston S. H., Reeve J. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med. 1998 Oct;244(4):271–292. doi: 10.1046/j.1365-2796.1998.00408.x. [DOI] [PubMed] [Google Scholar]
  25. Farthing M. J., Dawson A. M. Impaired semen quality in Crohn's disease--drugs, ill health, or undernutrition? Scand J Gastroenterol. 1983 Jan;18(1):57–60. doi: 10.3109/00365528309181559. [DOI] [PubMed] [Google Scholar]
  26. Farthing M. J., Rees L. H., Edwards C. R., Dawson A. M. Male gonadal function in coeliac disease: 2. Sex hormones. Gut. 1983 Feb;24(2):127–135. doi: 10.1136/gut.24.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Finkelstein J. S., Klibanski A., Neer R. M., Greenspan S. L., Rosenthal D. I., Crowley W. F., Jr Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987 Mar;106(3):354–361. doi: 10.7326/0003-4819-106-3-. [DOI] [PubMed] [Google Scholar]
  28. Greenberg G. R., Feagan B. G., Martin F., Sutherland L. R., Thomson A. B., Williams C. N., Nilsson L. G., Persson T. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology. 1996 Jan;110(1):45–51. doi: 10.1053/gast.1996.v110.pm8536887. [DOI] [PubMed] [Google Scholar]
  29. Grodstein F., Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Joffe M., Rosner B., Fuchs C., Hankinson S. E., Hunter D. J. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997 Jun 19;336(25):1769–1775. doi: 10.1056/NEJM199706193362501. [DOI] [PubMed] [Google Scholar]
  30. Hahn T. J., Halstead L. R., Teitelbaum S. L., Hahn B. H. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest. 1979 Aug;64(2):655–665. doi: 10.1172/JCI109506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jahnsen J., Falch J. A., Aadland E., Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut. 1997 Mar;40(3):313–319. doi: 10.1136/gut.40.3.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kiel D. P., Felson D. T., Anderson J. J., Wilson P. W., Moskowitz M. A. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med. 1987 Nov 5;317(19):1169–1174. doi: 10.1056/NEJM198711053171901. [DOI] [PubMed] [Google Scholar]
  33. Liberman U. A., Weiss S. R., Bröll J., Minne H. W., Quan H., Bell N. H., Rodriguez-Portales J., Downs R. W., Jr, Dequeker J., Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995 Nov 30;333(22):1437–1443. doi: 10.1056/NEJM199511303332201. [DOI] [PubMed] [Google Scholar]
  34. Lotz J. C., Gerhart T. N., Hayes W. C. Mechanical properties of trabecular bone from the proximal femur: a quantitative CT study. J Comput Assist Tomogr. 1990 Jan-Feb;14(1):107–114. doi: 10.1097/00004728-199001000-00020. [DOI] [PubMed] [Google Scholar]
  35. Lufkin E. G., Wahner H. W., O'Fallon W. M., Hodgson S. F., Kotowicz M. A., Lane A. W., Judd H. L., Caplan R. H., Riggs B. L. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 1992 Jul 1;117(1):1–9. doi: 10.7326/0003-4819-117-1-1. [DOI] [PubMed] [Google Scholar]
  36. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990 Mar 1;112(5):352–364. doi: 10.7326/0003-4819-112-5-352. [DOI] [PubMed] [Google Scholar]
  37. MacAdams M. R., White R. H., Chipps B. E. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med. 1986 May;104(5):648–651. doi: 10.7326/0003-4819-104-5-648. [DOI] [PubMed] [Google Scholar]
  38. Manolagas S. C., Jilka R. L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995 Feb 2;332(5):305–311. doi: 10.1056/NEJM199502023320506. [DOI] [PubMed] [Google Scholar]
  39. Marriott B. M. Vitamin D supplementation: a word of caution. Ann Intern Med. 1997 Aug 1;127(3):231–233. doi: 10.7326/0003-4819-127-3-199708010-00009. [DOI] [PubMed] [Google Scholar]
  40. Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996 May 18;312(7041):1254–1259. doi: 10.1136/bmj.312.7041.1254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mazure R., Vazquez H., Gonzalez D., Mautalen C., Pedreira S., Boerr L., Bai J. C. Bone mineral affection in asymptomatic adult patients with celiac disease. Am J Gastroenterol. 1994 Dec;89(12):2130–2134. [PubMed] [Google Scholar]
  42. McCloskey E. V., Murray S. A., Charlesworth D., Miller C., Fordham J., Clifford K., Atkins R., Kanis J. A. Assessment of broadband ultrasound attenuation in the os calcis in vitro. Clin Sci (Lond) 1990 Feb;78(2):221–225. doi: 10.1042/cs0780221. [DOI] [PubMed] [Google Scholar]
  43. McCloskey E. V., Murray S. A., Miller C., Charlesworth D., Tindale W., O'Doherty D. P., Bickerstaff D. R., Hamdy N. A., Kanis J. A. Broadband ultrasound attenuation in the os calcis: relationship to bone mineral at other skeletal sites. Clin Sci (Lond) 1990 Feb;78(2):227–233. doi: 10.1042/cs0780227. [DOI] [PubMed] [Google Scholar]
  44. McFarlane X. A., Bhalla A. K., Reeves D. E., Morgan L. M., Robertson D. A. Osteoporosis in treated adult coeliac disease. Gut. 1995 May;36(5):710–714. doi: 10.1136/gut.36.5.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Melton L. J., 3rd, Chrischilles E. A., Cooper C., Lane A. W., Riggs B. L. Perspective. How many women have osteoporosis? J Bone Miner Res. 1992 Sep;7(9):1005–1010. doi: 10.1002/jbmr.5650070902. [DOI] [PubMed] [Google Scholar]
  46. Messina O. D., Barreira J. C., Zanchetta J. R., Maldonado-Cocco J. A., Bogado C. E., Sebastián O. N., Flores D., Riopedre A. M., Redondo G., Lázaro A. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol. 1992 Oct;19(10):1520–1526. [PubMed] [Google Scholar]
  47. Molteni N., Caraceni M. P., Bardella M. T., Ortolani S., Gandolini G. G., Bianchi P. Bone mineral density in adult celiac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol. 1990 Jan;85(1):51–53. [PubMed] [Google Scholar]
  48. Mora S., Weber G., Barera G., Bellini A., Pasolini D., Prinster C., Bianchi C., Chiumello G. Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr. 1993 Feb;57(2):224–228. doi: 10.1093/ajcn/57.2.224. [DOI] [PubMed] [Google Scholar]
  49. Motley R. J., Crawley E. O., Evans C., Rhodes J., Compston J. E. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut. 1988 Oct;29(10):1332–1336. doi: 10.1136/gut.29.10.1332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Mulder H., Struys A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol. 1994 Apr;33(4):348–350. doi: 10.1093/rheumatology/33.4.348. [DOI] [PubMed] [Google Scholar]
  51. Orwoll E. S., Klein R. F. Osteoporosis in men. Endocr Rev. 1995 Feb;16(1):87–116. doi: 10.1210/edrv-16-1-87. [DOI] [PubMed] [Google Scholar]
  52. Overgaard K., Hansen M. A., Jensen S. B., Christiansen C. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ. 1992 Sep 5;305(6853):556–561. doi: 10.1136/bmj.305.6853.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pistorius L. R., Sweidan W. H., Purdie D. W., Steel S. A., Howey S., Bennett J. R., Sutton D. R. Coeliac disease and bone mineral density in adult female patients. Gut. 1995 Nov;37(5):639–642. doi: 10.1136/gut.37.5.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Porter R. W., Miller C. G., Grainger D., Palmer S. B. Prediction of hip fracture in elderly women: a prospective study. BMJ. 1990 Sep 29;301(6753):638–641. doi: 10.1136/bmj.301.6753.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Reid I. R., King A. R., Alexander C. J., Ibbertson H. K. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet. 1988 Jan 23;1(8578):143–146. doi: 10.1016/s0140-6736(88)92721-3. [DOI] [PubMed] [Google Scholar]
  56. Reid I. R. Preventing glucocorticoid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):420–421. doi: 10.1056/NEJM199708073370609. [DOI] [PubMed] [Google Scholar]
  57. Rickers H., Deding A., Christiansen C., Rødbro P., Naestoft J. Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration. Clin Endocrinol (Oxf) 1982 Apr;16(4):409–415. doi: 10.1111/j.1365-2265.1982.tb00734.x. [DOI] [PubMed] [Google Scholar]
  58. Sambrook P., Birmingham J., Kelly P., Kempler S., Nguyen T., Pocock N., Eisman J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993 Jun 17;328(24):1747–1752. doi: 10.1056/NEJM199306173282404. [DOI] [PubMed] [Google Scholar]
  59. Schaison G., Durand F., Mowszowicz I. Effect of glucocorticoids on plasma testosterone in men. Acta Endocrinol (Copenh) 1978 Sep;89(1):126–131. doi: 10.1530/acta.0.0890126. [DOI] [PubMed] [Google Scholar]
  60. Scott E. M., Scott B. B. A strategy for osteoporosis in gastroenterology. Eur J Gastroenterol Hepatol. 1998 Aug;10(8):689–698. [PubMed] [Google Scholar]
  61. Sheldon T. A., Raffle A., Watt I. Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing. BMJ. 1996 Feb 3;312(7026):296–297. doi: 10.1136/bmj.312.7026.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Silvennoinen J. A., Karttunen T. J., Niemelä S. E., Manelius J. J., Lehtola J. K. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995 Jul;37(1):71–76. doi: 10.1136/gut.37.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Steinberg K. K., Smith S. J., Thacker S. B., Stroup D. F. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology. 1994 Jul;5(4):415–421. doi: 10.1097/00001648-199407000-00007. [DOI] [PubMed] [Google Scholar]
  64. Storm T., Kollerup G., Thamsborg G., Genant H. K., Sørensen O. H. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. J Rheumatol. 1996 Sep;23(9):1560–1564. [PubMed] [Google Scholar]
  65. Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]
  66. Struys A., Snelder A. A., Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med. 1995 Sep;99(3):235–242. doi: 10.1016/s0002-9343(99)80154-5. [DOI] [PubMed] [Google Scholar]
  67. Valdimarsson T., Löfman O., Toss G., Ström M. Reversal of osteopenia with diet in adult coeliac disease. Gut. 1996 Mar;38(3):322–327. doi: 10.1136/gut.38.3.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Valdimarsson T., Toss G., Ross I., Löfman O., Ström M. Bone mineral density in coeliac disease. Scand J Gastroenterol. 1994 May;29(5):457–461. doi: 10.3109/00365529409096838. [DOI] [PubMed] [Google Scholar]
  69. Vogelsang H., Ferenci P., Resch H., Kiss A., Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995 Jul;7(7):609–614. [PubMed] [Google Scholar]
  70. Walters J. R., Banks L. M., Butcher G. P., Fowler C. R. Detection of low bone mineral density by dual energy x ray absorptiometry in unsuspected suboptimally treated coeliac disease. Gut. 1995 Aug;37(2):220–224. doi: 10.1136/gut.37.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Walters J. R. Bone mineral density in coeliac disease. Gut. 1994 Feb;35(2):150–151. doi: 10.1136/gut.35.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Watts N. B., Harris S. T., Genant H. K., Wasnich R. D., Miller P. D., Jackson R. D., Licata A. A., Ross P., Woodson G. C., 3rd, Yanover M. J. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990 Jul 12;323(2):73–79. doi: 10.1056/NEJM199007123230201. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES